Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Fitch Affirms CVS Caremark at 'BBB+'; Outlook Stable


Tuesday, 18 Dec 2012 06:28pm EST 

Fitch Ratings announced that it has affirmed its ratings on CVS Caremark Corp, including the long-term Issuer Default Rating (IDR) at 'BBB+'. The Rating Outlook is Stable. 

Company Quote

73.74
0.105 +0.14%
17 Apr 2014